The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal in Outpatient Surgeries - An Evaluation of Clinical and Associated Health Care Cost
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2019
Price : $35 *
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 28 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Jun 2019 Planned End Date changed from 1 May 2019 to 15 Dec 2019.
- 18 Jun 2019 Planned primary completion date changed from 1 May 2019 to 15 Dec 2019.